Dr. Agarwal’s Health Care Limited announced that Idearx Services Private Limited has ceased to be classified as an ‘Associate’ company, effective March 30, 2026. This follows an amendment to the Shareholders’ Agreement, terminating the Company’s specific rights over Idearx. Crucially, Dr. Agarwal’s retains its 14.54% equity stake in Idearx, maintaining all standard shareholder rights under law.
Formal Declaration of Associate Cessation
Dr. Agarwal’s Health Care Limited has officially informed the stock exchanges regarding a key change in its investment portfolio structure concerning Idearx Services Private Limited (“Idearx”). Pursuant to an amendment made to the Shareholders’ Agreement between the Company, the promoters, and other investors of Idearx, the status of Idearx has been formally changed.
The specific rights held by Dr. Agarwal’s Health Care Limited over Idearx, as stipulated in the original agreement, were terminated effective March 30, 2026. Consequently, Idearx is no longer considered an ‘Associate’ of the Company as of this date.
Retained Shareholding and Rights
Despite the cessation of its associate status, the Company confirms that its capital holding in Idearx remains unchanged. Dr. Agarwal’s Health Care Limited continues to hold 14.54% of the total equity share capital of Idearx. Furthermore, the announcement clarifies that all rights applicable to a standard shareholder under the Companies Act, 2013, or any other applicable laws, will remain intact for the Company.
This disclosure is made in furtherance of an earlier communication regarding the proposed amendment to the foundational agreement governing the relationship with Idearx.
Source: BSE
